XML 27 R5.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Statements of Cash Flows ( Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Cash flows from operating activities:    
Net income $ 47,492 $ 50,916
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 15,164 13,785
Amortization of deferred revenue (843) (317)
Amortization of deferred financing costs 1,095 1,095
Accretion of asset retirement obligations 199 187
Deferred income taxes 0 23
Loss on equity method investments 743 442
Gain on asset disposals (16) (18)
Unit-based compensation expense 414 298
Changes in assets and liabilities, net of acquisitions:    
Accounts receivable 21,557 (9,102)
Inventories and other current assets 3,808 5,645
Accounts payable and other current liabilities 775 (5,050)
Accounts receivable/payable to related parties (4,110) 9,046
Non-current assets and liabilities, net 483 (188)
Net cash provided by operating activities 86,761 66,762
Cash flows from investing activities:    
Business combinations 0 400
Purchases of property, plant and equipment (5,633) (17,598)
Proceeds from sales of property, plant and equipment 175 1,189
Equity method investments (54,703) (27,069)
Net cash used in investing activities (60,161) (43,878)
Cash flows from financing activities:    
Proceeds from issuance of additional units to maintain 2% General Partner interest 15 31
Distributions to general partner (6,861) (2,605)
Distributions to common unitholders - public (17,601) (15,193)
Distributions to common unitholders - Delek (15,578) (4,450)
Distributions to subordinated unitholders - Delek (11,503) (19,079)
Distributions to Delek for acquisitions 0 (61,890)
Proceeds from revolving credit facility 229,150 302,064
Payments of revolving credit facility (205,750) (228,664)
Predecessor division equity contribution 0 115
Reimbursement of capital expenditures by Delek 1,528 4,926
Net cash used in financing activities (26,600) (24,745)
Net decrease in cash and cash equivalents 0 (1,861)
Cash and cash equivalents at the beginning of the period 0 1,861
Cash and cash equivalents at the end of the period 0 0
Cash paid during the period for:    
Interest 8,902 6,289
Income taxes 0 5
Non-cash investing activities:    
Equity method investments 0 3,832
(Decreases) increases in accrued capital expenditures (624) 132
Non-cash financing activities:    
Sponsor contribution of fixed assets $ 609 $ 418